Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4424-4432

  Nelson, A E ^a   Howe, C J ^b   Nguyen, T V ^a   Leung, K C ^a   Trout, G J ^b   Seibel, M J ^c   Baxter, R C ^d   Handelsman, D J ^c   Kazlauskas, R ^b   Ho, K K ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b NATIONAL MEASUREMENT INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LABILE SUBUNIT; BIOLOGICAL MARKER; COLLAGEN; GROWTH HORMONE; PEPTIDE DERIVATIVE; PROCOLLAGEN C PROTEINASE; PROPEPTIDE OF TYPE I PROCOLLAGEN; PROPEPTIDE OF TYPE III PROCOLLAGEN; PROTEIN SUBUNIT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; TELOPEPTIDE OF TYPE I COLLAGEN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; ATHLETE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DOPING; ETHNOLOGY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SPORT;

EID: 33751541145     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0612     Document Type: Article

References (34)

1. Ehrnborg C, Bengtsson BA, Rosen T 2000 Growth hormone abuse. Baillieres Best Pract Res Clin Endocrinol Metab 14:71-77
2. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ 1999 Detection of doping with human growth hormone. Lancet 353:895
3. Tsushima T, Katoh Y, Miyachi Y, Chihara K, Teramoto A, Irie M, Hashimoto Y 1999 Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH. J Clin Endocrinol Metab 84:317-322
4. Leung KC, Howe C, Gui LY, Trout G, Veldhuis JD, Ho KK 2002 Physiological and pharmacological regulation of 20-kDa growth hormone. Am J Physiol Endocrinol Metab 283:E836-E843
5. Wallace JD, Cuneo RC, Bidlingmaier M, Lundberg PA, Carlsson L, Boguszewski CL, Hay J, Boroujerdi M, Cittadini A, Dall R, Rosen T, Strasburger CJ 2001 Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. J Clin Endocrinol Metab 86:1731-1737
6. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144
7. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
8. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:55-79
9. Seibel MJ 2000 Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 11(Suppl 6):S18-S29
10. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sonksen PH 2000 The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 85:4193-4200
11. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosen T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jorgensen JO, Sacca L 2000 Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 85:1505-1512
12. Kniess A, Ziegler E, Kratzsch J, Thieme D, Muller RK 2003 Potential parameters for the detection of hGH doping. Anal Bioanal Chem 376:696-700
13. Juul A 2003 Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113-170
14. Szulc P, Seeman E, Delmas PD 2000 Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281-294
15. Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Ashenden MJ, Gore CJ, Parisotto R, Hahn AG 2002 Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica 87:1248-1257
16. Baxter RC, Brown AS, Turtle JR 1982 Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem 28:488-495
17. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
18. Baxter RC 1990 Circulating levels and molecular distribution of the acid-labile (-) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70:1347-1353
19. Wright EM, Royston P 1999 Calculating reference intervals for laboratory measurements. Stat Methods Med Res 8:93-112
20. Healy ML, Dall R, Gibney J, Bassett E, Ehrnborg C, Pentecost C, Rosen T, Cittadini A, Baxter RC, Sonksen PH 2005 Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab 90:641-649
21. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E 1999 Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8:1107-1110
22. Wright NM, Papadea N, Willi S, Veldhuis JD, Pandey JP, Key LL, Bell NH 1996 Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausal women - a Clinical Research Center study. J Clin Endocrinol Metab 81:1023-1026
23. Hopkins KD, Lehmann ED, Jones RL, Holly JM, Cwyfan-Hughes SC, Turay RC, Teale JD, Gosling RG 1996 Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects. Clin Endocrinol (Oxf) 45:327-331
24. Tokita A, Kelly PJ, Nguyen TV, Qi JC, Morrison NA, Risteli L, Risteli J, Sambrook PN, Eisman JA 1994 Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab 78:1461-1466
25. Livshits G, Yakovenko C, Kobyliansky E 2000 Quantitative genetic analysis of circulating levels of biochemical markers of bone formation. Am J Med Genet 94:324-331
26. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542
27. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP 1991 Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 30:276-280
28. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y 1995 Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone 17:397-401
29. Lindqvist U, Laurent TC 1992 Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 52:613-621
30. Fatayerji D, Eastell R 1999 Age-related changes in bone turnover in men. J Bone Miner Res 14:1203-1210
31. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
32. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L 2004 Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13:1444-1451
33. Midtby M, Magnus JH, Joakimsen RM 2001 The Tromso Study: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women. Osteoporos Int 12:835-843
34. Sartorio A, Agosti F, Marazzi N, Maffiuletti NA, Cella SG, Rigamonti AE, Guidetti L, Di Luigi L, Muller EE 2004 Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report. Clin Endocrinol (Oxf) 61:487-493